RT Journal Article SR Electronic T1 Estimating the effect of mobility on SARS-CoV-2 transmission during the first and second wave of the COVID-19 epidemic in Switzerland: a population-based study JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.04.16.21255636 DO 10.1101/2021.04.16.21255636 A1 Adrian Lison A1 Joel Persson A1 Nicolas Banholzer A1 Stefan Feuerriegel YR 2021 UL http://medrxiv.org/content/early/2021/04/20/2021.04.16.21255636.abstract AB The effect of mobility and its value for surveillance in different waves of the COVID-19 epidemic is still unclear. In this study, we compared the role of mobility during the first and second epidemic wave in Switzerland by analysing the link between daily travel distances and the effective reproduction number Rt of SARS-CoV-2. Here we used aggregated mobile phone data from a representative panel survey of the Swiss population to measure human mobility. We estimated the effects of reductions in daily travel distance on Rt via a regression model. We compared mobility effects between the first wave (March 2-April 7, 2020) and the second wave (October 1-December 10, 2020) across mode of transport, travel purpose, sociodemographic subgroup and movement radius. We found that human mobility was associated with the effective reproduction number of SARS-CoV-2 during both the first and second epidemic wave in Switzerland. The estimated relative effects of mobility were similar in both waves for all modes of transport, travel purposes, and sociodemographic subgroups but differed by movement radius. Moreover, smaller mobility reductions in the second wave translated into smaller overall reductions of Rt. Mobility data from mobile phones have a continued potential to support real-time surveillance of COVID-19 during epidemic waves.Competing Interest StatementSF declares membership in a COVID-19 Working Group by the World Health Organization (WHO) but without competing interests. SF reports grants from the Swiss National Science Foundation outside of the submitted work. All other authors declare no competing interests.Funding StatementThis work has received financial support from the Swiss National Science Foundation (SNSF) as part of the Eccellenza grant 186932 on "Data-driven health management". The funding source had no role in study design, data collection, data analysis, interpretation, writing of the manuscript, or decision to submit.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval (EK 2020-N-179) for this study was obtained by the institutional review board at ETH Zurich.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in this study are publicly available. Mobility data are available from intervista AG. Estimates of the effective reproduction number are available from the Swiss National COVID-19 Science Task Force. Data on policy measures and testing are available from the Swiss Federal Office of Public Health. https://www.intervista.ch/media/2020/03/Report_Mobilit%C3%A4ts-Monitoring_Covid-19.pdf https://sciencetaskforce.ch/en/current-situation/ https://www.bag.admin.ch/bag/en/home.html